Top compounds associated with response to ADAM18


Feature Type Standardized
Nominal ANOVA
mRNA AMG-706 GDSC1000 pan-cancer AAC 0.084 0.01
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
mRNA paclitaxel gCSI pan-cancer AAC -0.12 0.02
mRNA Docetaxel gCSI pan-cancer AAC -0.12 0.02
mRNA Topotecan CTRPv2 pan-cancer AAC -0.076 0.02
mRNA FH535 GDSC1000 pan-cancer AAC 0.077 0.02
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.081 0.02
mRNA Erlotinib CCLE pan-cancer AAC -0.099 0.03
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.073 0.03
Download CSV